Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 09, 2020 08:30 ET | Source: Phathom Pharmaceuticals

Phathom Pharmaceuticals to Present at Morgan Stanley 18th Annual Global Healthcare Conference

FLORHAM PARK, N.J., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel...
August 06, 2020 08:30 ET | Source: Phathom Pharmaceuticals

Phathom Pharmaceuticals Reports Second Quarter 2020 Results

FLORHAM PARK, N.J., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel...
July 13, 2020 08:30 ET | Source: Phathom Pharmaceuticals

Phathom Pharmaceuticals Announces Appointment of Todd Branning as Chief Financial Officer

FLORHAM PARK, N.J., July 13, 2020 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel...
June 15, 2020 08:30 ET | Source: Phathom Pharmaceuticals

Phathom Pharmaceuticals Provides Clinical Trial Status Update

FLORHAM PARK, N.J., June 15, 2020 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel...
May 28, 2020 16:30 ET | Source: Phathom Pharmaceuticals

Phathom Pharmaceuticals to Present at Upcoming Investor Conferences

FLORHAM PARK, N.J., May 28, 2020 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel...
May 12, 2020 08:30 ET | Source: Phathom Pharmaceuticals

Phathom Pharmaceuticals Reports First Quarter 2020 Results

FLORHAM PARK, N.J., May 12, 2020 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel...
April 09, 2020 16:30 ET | Source: Phathom Pharmaceuticals

Phathom to Participate at the 19th Annual Needham Virtual Healthcare Conference

FLORHAM PARK, N.J., April 09, 2020 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel...
March 19, 2020 08:30 ET | Source: Phathom Pharmaceuticals

Phathom Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Clinical Trial Status and Business Updates

Successfully Finished 2019 with Initiation of Two Pivotal Phase 3 Trials for Vonoprazan in Erosive Esophagitis (PHALCON-EE) and H. pylori Infection (PHALCON-HP) and Completion of $209M Initial Public...
February 25, 2020 16:35 ET | Source: Phathom Pharmaceuticals

Phathom Pharmaceuticals to Present at 40th Annual Cowen and Company Health Care Conference on March 2, 2020

FLORHAM PARK, N.J., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel...